We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+0.75%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$104B
AUM Growth
+$704M
Cap. Flow
-$915M
Cap. Flow %
-0.88%
Top 10 Hldgs %
14.25%
Holding
2,771
New
148
Increased
1,779
Reduced
566
Closed
77

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$191M
2
SCHW
Charles Schwab
SCHW
+$157M
3
PFE icon
Pfizer
PFE
+$139M
4
MMM icon
3M
MMM
+$131M
5
META icon
Meta Platforms (Facebook)
META
+$106M

Sector Composition

Rank Sector Weight
1 Healthcare 17.28%
2 Financials 14.69%
3 Technology 14.25%
4 Consumer Discretionary 9.55%
5 Industrials 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYG icon
551
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
0
NRG icon
552
NRG Energy
NRG
$28.3B
$30.2M 0.03%
1,319,160
+4,319
+0.3% +$108K
MD icon
553
Pediatrix Medical
MD
$2.18B
$30.1M 0.03%
406,735
+75,633
+23% +$5.44M
WPM icon
554
Wheaton Precious Metals
WPM
$49.5B
$30M 0.03%
1,727,175
-123,371
-7% -$2.37M
EWJ icon
555
iShares MSCI Japan ETF
EWJ
$22B
$29.9M 0.03%
583,333
+3,195
+0.6% +$166K
TSS
556
DELISTED
Total System Services, Inc.
TSS
$29.6M 0.03%
709,837
+71,295
+11% +$2.88M
CE icon
557
Celanese
CE
$4.9B
$29.6M 0.03%
412,122
-2,236
-0.5% -$149K
JOY
558
DELISTED
Joy Global Inc
JOY
$29.6M 0.03%
817,974
-243,008
-23% -$9.78M
PII icon
559
Polaris
PII
$3.82B
$29.6M 0.03%
199,857
-8,597
-4% -$1.24M
DST
560
DELISTED
DST Systems Inc.
DST
$29.6M 0.03%
469,618
+33,846
+8% +$2.01M
MAS icon
561
Masco
MAS
$14.1B
$29.5M 0.03%
1,258,611
-12,503
-1% -$296K
CLDX icon
562
Celldex Therapeutics
CLDX
$2.99B
$29.5M 0.03%
77,870
+2,295
+3% +$911K
HRB icon
563
H&R Block
HRB
$5.58B
$29.4M 0.03%
992,262
-23,928
-2% -$751K
CINF icon
564
Cincinnati Financial
CINF
$27.3B
$29.3M 0.03%
584,450
-10,097
-2% -$521K
BRK.A icon
565
Berkshire Hathaway Class A
BRK.A
$1.1T
$29.3M 0.03%
143
DNB
566
DELISTED
Dun & Bradstreet
DNB
$29.2M 0.03%
238,949
-2,513
-1% -$323K
FLR icon
567
Fluor
FLR
$7.01B
$29M 0.03%
547,978
-204,902
-27% -$11.8M
TAP icon
568
Molson Coors Class B
TAP
$7.79B
$28.9M 0.03%
414,561
+6,733
+2% +$501K
MLM icon
569
Martin Marietta Materials
MLM
$31.5B
$28.8M 0.03%
203,689
-7,999
-4% -$1.17M
MAT icon
570
Mattel
MAT
$4.38B
$28.8M 0.03%
1,120,899
-10,060
-0.9% -$265K
PBA icon
571
Pembina Pipeline
PBA
$28.4B
$28.7M 0.03%
887,591
+17,956
+2% +$601K
IMO icon
572
Imperial Oil
IMO
$62.7B
$28.6M 0.03%
740,094
+16,403
+2% +$675K
UAL icon
573
United Airlines
UAL
$39.4B
$28.4M 0.03%
534,966
+125,697
+31% +$7.28M
VER
574
DELISTED
VEREIT, Inc.
VER
$28M 0.03%
688,447
-335,762
-33% -$15.2M
HAS icon
575
Hasbro
HAS
$13.2B
$28M 0.03%
374,033
-3,964
-1% -$282K

Similar funds

UBS AM's Q2 2015 Portfolio in Review

As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.

  • UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
  • UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
  • UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
  • UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
  • UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
  • UBS AM opened 148 new positions and closed 77 in Q2 2015.
  • UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.

Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.